These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25188519)

  • 21. Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma.
    Wu H; Wang W; Liu F; Weisberg EL; Tian B; Chen Y; Li B; Wang A; Wang B; Zhao Z; McMillin DW; Hu C; Li H; Wang J; Liang Y; Buhrlage SJ; Liang J; Liu J; Yang G; Brown JR; Treon SP; Mitsiades CS; Griffin JD; Liu Q; Gray NS
    ACS Chem Biol; 2014 May; 9(5):1086-91. PubMed ID: 24556163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.
    Chiron D; Di Liberto M; Martin P; Huang X; Sharman J; Blecua P; Mathew S; Vijay P; Eng K; Ali S; Johnson A; Chang B; Ely S; Elemento O; Mason CE; Leonard JP; Chen-Kiang S
    Cancer Discov; 2014 Sep; 4(9):1022-35. PubMed ID: 25082755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.
    Bagheri-Yarmand R; Mandal M; Taludker AH; Wang RA; Vadlamudi RK; Kung HJ; Kumar R
    J Biol Chem; 2001 Aug; 276(31):29403-9. PubMed ID: 11382770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tyrosine kinases and autophagy in prostate cancer.
    Kung HJ
    Horm Cancer; 2011 Feb; 2(1):38-46. PubMed ID: 21350583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
    J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation.
    Zhang Z; Zhu W; Zhang J; Guo L
    Cancer Biol Ther; 2011 Apr; 11(7):690-8. PubMed ID: 21339702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage.
    Jiang T; Guo Z; Dai B; Kang M; Ann DK; Kung HJ; Qiu Y
    J Biol Chem; 2004 Nov; 279(48):50181-9. PubMed ID: 15355990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and biological activity of imidazole group-substituted arylaminopyrimidines (IAAPs) as potent BTK inhibitors against B-cell lymphoma and AML.
    Li S; Wu B; Zheng X; Wang C; Zhao J; Sun H; Sun X; Tang Z; Yuan H; Chen L; Ma X
    Bioorg Chem; 2021 Jan; 106():104385. PubMed ID: 33272709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
    Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
    Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.
    Wu H; Hu C; Wang A; Weisberg EL; Chen Y; Yun CH; Wang W; Liu Y; Liu X; Tian B; Wang J; Zhao Z; Liang Y; Li B; Wang L; Wang B; Chen C; Buhrlage SJ; Qi Z; Zou F; Nonami A; Li Y; Fernandes SM; Adamia S; Stone RM; Galinsky IA; Wang X; Yang G; Griffin JD; Brown JR; Eck MJ; Liu J; Gray NS; Liu Q
    Leukemia; 2016 Jan; 30(1):173-81. PubMed ID: 26165234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
    Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
    Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.
    Tomlinson MG; Kane LP; Su J; Kadlecek TA; Mollenauer MN; Weiss A
    Mol Cell Biol; 2004 Mar; 24(6):2455-66. PubMed ID: 14993283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Pteridine-7(8
    Dou D; Diao Y; Sha W; Su R; Tong L; Li W; Leng L; Xie L; Yu Z; Song H; Shen Z; Zhu L; Zhao Z; Xie H; Chen Z; Li H; Xu Y
    J Med Chem; 2022 Feb; 65(3):2694-2709. PubMed ID: 35099969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway.
    Sivaganesh V; Ta TM; Peethambaran B
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
    Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
    Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective TBK1/IKKi dual inhibitors with anticancer potency.
    Li J; Huang J; Jeong JH; Park SJ; Wei R; Peng J; Luo Z; Chen YT; Feng Y; Luo JL
    Int J Cancer; 2014 Apr; 134(8):1972-80. PubMed ID: 24150799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells.
    Jiang X; Borgesi RA; McKnight NC; Kaur R; Carpenter CL; Balk SP
    J Biol Chem; 2007 Nov; 282(45):32689-98. PubMed ID: 17823122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.
    Chang YM; Bai L; Liu S; Yang JC; Kung HJ; Evans CP
    Oncogene; 2008 Oct; 27(49):6365-75. PubMed ID: 18679417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.